168 related articles for article (PubMed ID: 31076928)
21. ASO Author Reflections: High-Dose Radiation Offers Local Control for Inoperable Intrahepatic Cholangiocarcinoma.
Smart AC; Wo JY
Ann Surg Oncol; 2020 Apr; 27(4):1130-1131. PubMed ID: 31858298
[No Abstract] [Full Text] [Related]
22. Recurrent cholangiocarcinoma: negative autopsy results after aggressive management.
Ashamalla H; Kostandy G; Salama S; Ghaly M; Taha H; Toni E; Sosler B; Chandra P
South Med J; 2000 Jun; 93(6):603-5. PubMed ID: 10881779
[TBL] [Abstract][Full Text] [Related]
23. ASO Author Reflections: Association of Perioperative Red Blood Cell Transfusion with Increased Disease Recurrence and Worse Survival After Resection of Distal Cholangiocarcinoma.
Lopez-Aguiar AG; Maithel SK
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):654-655. PubMed ID: 31286311
[No Abstract] [Full Text] [Related]
24. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
[TBL] [Abstract][Full Text] [Related]
25. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma.
Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Loilome W
BMC Cancer; 2020 Feb; 20(1):154. PubMed ID: 32093644
[TBL] [Abstract][Full Text] [Related]
26. ASO Author Reflections: Optimizing the Oncological Outcome for Locally Advanced Intrahepatic Cholangiocarcinoma.
Li J; Moustafa M; Meiners J; Stüben O; Izbicki J; Heumann A
Ann Surg Oncol; 2020 May; 27(5):1385-1386. PubMed ID: 32124123
[No Abstract] [Full Text] [Related]
27. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
[TBL] [Abstract][Full Text] [Related]
28. Surgical treatment for intrahepatic cholangiocarcinoma.
Uenishi T; Yamamoto T; Takemura S; Kubo S
Clin J Gastroenterol; 2014 Apr; 7(2):87-93. PubMed ID: 26183622
[TBL] [Abstract][Full Text] [Related]
29. Intrahepatic cholangiocarcinoma.
Nuzzo G; Giuliante F; Ardito F; Giovannini I
Ann Surg; 2009 Mar; 249(3):541-2; author reply 542. PubMed ID: 19247046
[No Abstract] [Full Text] [Related]
30. Management and extent of resection for intrahepatic cholangiocarcinoma.
Carpizo DR; D'Angelica M
Surg Oncol Clin N Am; 2009 Apr; 18(2):289-305, viii-ix. PubMed ID: 19306813
[TBL] [Abstract][Full Text] [Related]
31. ASO Author Reflections: Impact of Tumor Necrosis on Prognosis of Patients Undergoing Resection for T1 Intrahepatic Cholangiocarcinoma.
Tsilimigras DI; Pawlik TM
Ann Surg Oncol; 2022 May; 29(5):2975-2976. PubMed ID: 35217976
[No Abstract] [Full Text] [Related]
32. Outcomes of resection for solitary ≤5 cm intrahepatic cholangiocarcinoma.
Tarchi P; Tabrizian P; Prigoff J; Schwartz M
Surgery; 2018 Apr; 163(4):698-702. PubMed ID: 29277385
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative frozen section diagnosis of bile duct margin for extrahepatic cholangiocarcinoma.
Shiraki T; Kuroda H; Takada A; Nakazato Y; Kubota K; Imai Y
World J Gastroenterol; 2018 Mar; 24(12):1332-1342. PubMed ID: 29599608
[TBL] [Abstract][Full Text] [Related]
34. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous transhepatic biliary drainage catheter tract recurrence in cholangiocarcinoma.
Takahashi Y; Nagino M; Nishio H; Ebata T; Igami T; Nimura Y
Br J Surg; 2010 Dec; 97(12):1860-6. PubMed ID: 20799295
[TBL] [Abstract][Full Text] [Related]
36. Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.
Hong JC; Petrowsky H; Kaldas FM; Farmer DG; Durazo FA; Finn RS; Saab S; Han SH; Lee P; Markovic D; Lassman C; Hiatt JR; Busuttil RW
J Am Coll Surg; 2011 Apr; 212(4):514-20; discussion 520-1. PubMed ID: 21463781
[TBL] [Abstract][Full Text] [Related]
37. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
[TBL] [Abstract][Full Text] [Related]
38. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery.
Park HM; Yun SP; Lee EC; Lee SD; Han SS; Kim SH; Park SJ
Ann Surg Oncol; 2016 Dec; 23(13):4392-4400. PubMed ID: 27581609
[TBL] [Abstract][Full Text] [Related]
39. ASO Author Reflections: Bile Duct Resection-Is It Beneficial for Distal Cholangiocarcinoma?
Ebata T; Jikei K; Mizuno T
Ann Surg Oncol; 2021 Apr; 28(4):2000. PubMed ID: 33094374
[No Abstract] [Full Text] [Related]
40. [Liver, pancreas, biliary tract cancer. II. Current Status of Combined Vascular Resection for Perihilar Cholangiocarcinoma].
Ebata T; Yokoyama Y; Sugawara G; Igami T; Mizuno T; Fukaya M; Uehara K; Yamaguchi J; Kokuryo T; Nagino M
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1212-5. PubMed ID: 25528774
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
